American Health Packaging Recalls Ibuprofen Due to Label Mix-Up
American Health Packaging recalls specific lots of 600 mg Ibuprofen tablets due to a labeling error where blister cards were misidentified as Oxcarbazepine.
Stop using this now
Labeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that contain blister cards filled with Ibuprofen tablets, 600mg drug product, were found to be mis-labeled with blister card print identifying the product as AHP Oxcarbazepine Tablets, 300mg, lot #142544
Contact the company
What happened, in plain English
American Health Packaging is recalling Ibuprofen Tablets, USP, 600 mg because some cartons were found with incorrect labeling. The blister cards inside these specific lots were printed to identify the product as AHP Oxcarbazepine Tablets instead of Ibuprofen. This creates a risk that patients could take the wrong medication if they rely on the label for identification. Read more at govinfonow.com/recall/45966-american-health-packaging-recalls-ibuprofen-tablets-usp-600-mg-100.
Source Summary by GovInfoNow · govinfonow.com/recall/45966-american-health-packaging-recalls-ibuprofen-tablets-usp-600-mg-100 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1589-2014
Cite this page
“American Health Packaging Recalls Ibuprofen Due to Label Mix-Up.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45966-american-health-packaging-recalls-ibuprofen-tablets-usp-600-mg-100. Based on FDA recall #D-1589-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1589-2014%22&limit=1).
Why it’s dangerous
The hazard is a labeling mix-up where Ibuprofen tablets were packaged in blister cards labeled as Oxcarbazepine. If a patient or caregiver reads the label instead of verifying the pill itself, they may administer Oxcarbazepine when Ibuprofen was intended, or vice versa, leading to potential adverse drug events.
Who’s affected
Patients who have purchased or been prescribed Ibuprofen Tablets, USP, 600 mg from American Health Packaging, specifically those with lot number 142588. Individuals relying on the blister card label to distinguish between their medications are at risk of taking the wrong drug.
How to tell if you have this one
Check your medication carton for the brand 'American Health Packaging' and the product name 'Ibuprofen Tablets, USP, 600 mg'. Look specifically for NDC 68084-0703-01 and Lot #142588 with an expiration date of 01/2016. Verify that the blister card inside matches the Ibuprofen label and does not say 'Oxcarbazepine'.
- Brand
American Health Packaging- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class I- Status
Terminated- Distribution
Nationwide and Puerto Rico
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1589-2014 | Ibuprofen Tablets, USP, 600 mg, 100 tablets per carton (10 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, OH 43217, NDC 68084-0703-01; Lot #142588, Exp 01/2016 | 137,300 tablets |
| D-1590-2014 | Oxcarbazepine Tablets, 300 mg, 100 tablets per carton (10 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, OH 43217, NDC 62584-143-01; Lot #142544, Exp 02/2016 | 59,200 tablets |
What to do — step by step
Stop using the medication
Do not take the tablets from the recalled cartons until you have verified the lot number and expiration date.
Verify your lot number
Check if your package has Lot #142588 and Exp 01/2016 to confirm if it is part of this specific recall.
Contact your pharmacist or doctor
Consult with a healthcare professional regarding the proper disposal of the recalled product and obtaining a replacement.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 13 months after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Where was this product distributed?
The recalled product was distributed nationwide and in Puerto Rico.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1589-2014 (July 1, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1589-2014 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.